AddLife ABOSTO:ALIF B +4.77%85 OCF Margin % is 3.93% as of Mar. 2026, which is 62% below its 10-year median of 10.33. GuruFocus rates OSTO:ALIF B with a GF Score™ of 85/100 and a GF Value™ of kr147.35 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, AddLife AB ranks better than 61.84% on this metric.
The historical rank and industry rank for AddLife AB's OCF Margin % or its related term are showing as below:
OSTO:ALIF B'
s OCF Margin % Range Over the Past 10 Years
Min: 7.15 Med: 10.33 Max: 18.02
Current: 12.09
During the past 13 years, the highest OCF Margin % of AddLife AB was 18.02%. The lowest was 7.15%. And the median was 10.33%.
OSTO:ALIF B's OCF Margin % is ranked better than 61.84% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs OSTO:ALIF B: 12.09
AddLife AB OCF Margin % Related Terms
AddLife AB OCF Margin % Historical Data
* Premium members only.
The historical data trend for AddLife AB's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ALIF B vs ISRG, BDX, MDLN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, AddLife AB's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AddLife AB OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's OCF Margin % distribution charts can be found below:
* The bar in red indicates where AddLife AB's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AddLife AB (OSTO:ALIF B) has a OCF Margin % of 3.93% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on AddLife AB and its competitors. This is 62% below median its historical median of 10.33. Over the past decade, AddLife AB's OCF Margin % has ranged from 7.15 to 18.02. According to the industry distribution chart, AddLife AB ranks #311 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 38.2%.
Is AddLife AB's OCF Margin % too high?
AddLife AB's current OCF Margin % of 3.93% is 62% below median its 10-year median of 10.33. Over the past 10 years, this metric has ranged from a low of 7.15 to a high of 18.02. The Medical Devices & Instruments industry median OCF Margin % is 5.86. AddLife AB's value of 3.93% is 32.9% below this industry median. Based on the distribution chart, AddLife AB ranks #311 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, AddLife AB has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AddLife AB's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, AddLife AB ranks #311 out of 815 companies for OCF Margin %. This puts AddLife AB in the upper half of its industry. The industry median OCF Margin % is 5.86. AddLife AB's value of 3.93% is 32.9% below this benchmark. Historically, AddLife AB's own OCF Margin % has ranged from 7.15 to 18.02 over the past decade. While the company's 10-year median is 10.33 vs. the industry median of 5.86, AddLife AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AddLife AB's current OCF Margin % of 3.93% is 32.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on AddLife AB and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AddLife AB's current OCF Margin % is 3.93%, which is 62% below median its own 10-year median of 10.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AddLife AB stock overvalued right now?
Based on GuruFocus' analysis, AddLife AB (OSTO:ALIF B) is currently considered Modestly Overvalued. The stock's GF Value™ is kr147.35, compared to a current price of kr166.80 — trading 13.2% above its estimated fair value. The current OCF Margin % is 3.93%, which is 62% below median its 10-year median of 10.33 and 32.9% below the Medical Devices & Instruments industry median of 5.86. AddLife AB's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For AddLife AB (OSTO:ALIF B), the current OCF Margin % is 3.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AddLife AB (OSTO:ALIF B) Overvalued in 2026?
Based on GuruFocus' analysis, AddLife AB stock appears to be overvalued.
The current stock price of kr166.80 is trading 13.2% above its estimated GF Value™ of kr147.35.
GuruFocus considers AddLife AB to be Modestly Overvalued.
Key valuation signals for OSTO:ALIF B:
OCF Margin %: 3.93% (62% below median its 10-year median of 10.33)
GF Value™: kr147.35 vs. price of kr166.80 (13.2% above fair value)
Industry Position: 32.9% below the Medical Devices & Instruments median (#311 of 815)
No single metric tells the full story. See the OSTO:ALIF B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech. The Labtech segment provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service to laboratories in medicine, research, academia and the food and pharmaceutical industries. The Medtech segment includes a range that spans from basic consumables to instruments for surgical procedures, welfare technology, and assistive devices for the elderly and disabled. The majority of revenue is derived from the Medtech segment.
85GF Score
Get the complete analysis for OSTO:ALIF B
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ALIF B has been successfully added to your 
